Ozempic Shrinks Wall Street: Tailors See Wardrobe Revolution

Wall Street professionals are undergoing significant transformations, with many investment bankers and executives returning to tailors with much slimmer frames. This shift, largely driven by the widespread use of GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro, has led to a dramatic increase in suit alterations. Tailors like Michael Andrews in New York have seen clients bring back entire wardrobes, with dozens of garments requiring extensive adjustments due to substantial weight loss, sometimes reaching 20 to 30 pounds.

This trend, dubbed the 'Ozempic effect,' is reshaping the tailoring business. Andrews reported a more than tenfold increase in suit take-ins in 2025 compared to previous years, prompting him to expand his team. Other tailors echo this sentiment, noting a "dramatic impact" on their businesses. While alteration costs have risen, some see an upside as clients who achieve their desired weight often opt for entirely new wardrobes, reflecting a significant shift in consumer behavior and business demand.

In 2025, the number of requests to enlarge garments was significantly outweighed by those to make them smaller, with one tailor receiving 192 requests for take-ins versus only 17 for enlargements. This indicates a sustained and widespread trend of weight reduction among Wall Street clientele. The desire to accentuate weight loss is also influencing style preferences, with clients opting for trimmer fits and reduced padding in their suits, signaling a new era in bespoke fashion dictated by medical advancements.